Learn more

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NATSIONALNYJ ISSLEDOVATELSKIJ TSENTR EPIDEMIOLOG

Overview
  • Total Patents
    18
  • GoodIP Patent Rank
    95,553
  • Filing trend
    ⇩ 14.0%
About

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NATSIONALNYJ ISSLEDOVATELSKIJ TSENTR EPIDEMIOLOG has a total of 18 patent applications. It decreased the IP activity by 14.0%. Its first patent ever was published in 2015. It filed its patents most often in Russian Federation. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES, MIRUS BIO CORP and GAMMA VACCINES PTY LTD.

Patent filings in countries

World map showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NATSIONALNYJ ISSLEDOVATELSKIJ TSENTR EPIDEMIOLOGs patent filings in countries
# Country Total Patents
#1 Russian Federation 18

Patent filings per year

Chart showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NATSIONALNYJ ISSLEDOVATELSKIJ TSENTR EPIDEMIOLOGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gintsburg Aleksandr Leonidovich 11
#2 Logunov Denis Yurevich 9
#3 Naroditskij Boris Savelevich 8
#4 Shcherbinin Dmitrij Nikolaevich 6
#5 Shmarov Maksim Mikhajlovich 6
#6 Shcheblyakov Dmitrij Viktorovich 6
#7 Tukhvatulin Amir Ildarovich 6
#8 Borisevich Sergej Vladimirovich 5
#9 Zubkova Olga Vadimovna 5
#10 Dolzhikova Inna Vadimovna 4

Latest patents

Publication Filing date Title
RU2731356C1 Expression vector for creating immunobiological agent for inducing specific immunity to virus of severe acute respiratory syndrome sars-cov-2 (embodiments)
RU2731342C1 Pharmaceutical agent and method for use thereof for inducing specific immunity to virus of severe acute respiratory syndrome sars-cov-2 (embodiments)
RU2720518C1 Strain of sindbis fever virus 1383 clone 3
RU2722648C2 Method for immunogenicity testing of vaccine antigens for producing highly effective vaccines against dangerous infections
RU2713722C1 STRAIN OF A RECOMBINANT PSEUDO ADENOVIRAL PARTICLE BASED ON HUMAN ADENOVIRUS GENOME OF SEROTYPE 5 Ad5-tetOFF-E3-HA125 SEROTYPE, CARRYING HAEMAGGLUTININ CONSENSUS GENE OF INFLUENZA VIRUS SUBTYPES H1, H2, H5 FOR PRODUCING INFLUENZA IMMUNOGENIC PREPARATIONS, METHOD FOR PRODUCING GENE
RU2709659C1 Immunobiological agent and a method for use thereof for inducing specific immunity to the middle eastern respiratory syndrome virus (versions)
RU2701737C1 Medicinal agent for chronic wound therapy
RU2691302C1 Immunogenic composition based on recombinant pseudo adenoviral particles, as well as based on protein antigens and a method for producing an immunogenic composition
RU2686630C1 Strains of hybrid cells of animals mus_ musculus - producers of monoclonal antibodies to protein gp of ebola virus (subtype zaire) and monoclonal antibodies to protein gp of ebola virus (subtype zaire)
RU2676699C1 Amino acid derivatives of 2-norbornane-acetic acid and their antiviral activity against influenza viruses
RU2670204C1 Derivatives of 2-thiouracil with antiadenoviral activity
RU2665817C1 Recombinant tuberculous vaccine and adjuvant for it
RU2663137C1 Substituted hydrazons of 5-arylfurfurols - intrycellular inhibitors of brucell
RU2709657C2 Method for lyophilic drying of attenuated bacteria b.pertussis, attenuated bacteria b. pertussis, strain of attenuated b. pertussis bacteria, vaccine, lyophilized vaccine preparation
RU2641297C1 Cyclohexanoxycarbonyl-dipeptide and its antiviral activity against hepatitis c virus
RU2661028C2 Pharmaceutical composition for passive rabies immunization, pharmaceutical kit, pharmaceutical kit application method
RU2676768C2 Chlamydial vaccine and method for its preparation
RU2644202C2 Single-domain antibodies to ebola virus gp protein for immunotherapy of ebola fever